Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Palladium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102399165B reveals a high-yield Chloramphenicol synthesis using nitromethane, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112110933A reveals a novel Pd-catalyzed route for high-purity lignan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110642843A reveals a novel Pd-catalyzed asymmetric [3+2] cyclization for high-purity chiral isonucleosides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103570600B reveals Pd-catalyzed asymmetric amination for chiral beta-lactams. Enables cost reduction in pharmaceutical manufacturing with high enantioselectivity.
Patent CN107382644B details a novel Pd-B co-catalyzed asymmetric method for chiral tertiary alcohols, offering high ee and mild conditions for antifungal drug manufacturing.
Discover advanced Pd-catalyzed synthesis for chiral beta-lactams. High enantioselectivity and scalable processes for reliable pharmaceutical intermediates supply chains.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Novel chiral epoxy propyl benzo-heterocycle synthesis for ROMK inhibitors. High ee, scalable route for pharmaceutical intermediates supply.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.
Patent CN111848374A details a streamlined 10-step asymmetric synthesis of high-purity gossypol enantiomers, offering significant cost reduction and scalability for API manufacturing.
Patent CN101260085A reveals a high-efficiency palladium-catalyzed asymmetric hydrogenation route for chiral gamma-sultams, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN115991667A details a novel Pd-catalyzed method for synthesizing chiral 3-substituted indolines with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Advanced Pd-catalyzed synthesis of chiral tetrahydrofuran acetals enables high-purity lignan intermediates. Discover cost-effective supply chain solutions.
Discover the novel 4-step synthesis of Montelukast Sodium intermediate via patent CN115710221A. Achieve high purity, reduced costs, and scalable supply chain solutions.
Patent CN110204491B details a novel Pd-catalyzed asymmetric C-H functionalization route for chiral 3,4-dihydroisoquinolinones, offering superior selectivity and cost efficiency for pharmaceutical manufacturing.
Patent CN103665036B details novel chiral ligands enabling high-purity pharmaceutical intermediate manufacturing with significant cost reduction and supply chain reliability.
Patent CN110590781B reveals a novel Pd-catalyzed asymmetric allylic amination route for high-purity antiviral intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel two-step synthesis of axial chiral ligands from aryl halides offers cost-effective, high-enantioselectivity solutions for pharmaceutical manufacturing.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.